Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis
- PMID: 6734706
- DOI: 10.1007/BF00542141
Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis
Abstract
The protein binding of piroxicam in synovial fluid and plasma from patients with rheumatoid arthritis was studied in vitro by equilibrium dialysis. The binding parameters were calculated from the experimental data with the Scatchard model, assuming binding to two classes of sites. Each plasma sample was diluted to an albumin concentration equal to that of synovial fluid from the same patient. The association constants for primary and secondary binding sites in the concentration range of piroxicam 4.5-90 X 10(-5) mol/l were similar in synovial fluid and in plasma. For synovial fluid K1 = 2.38 X 10(5) l/mol and K2 = 2.29 X 10(3) l/mol; for plasma K1 = 1.93 X 10(5) l/mol and K2 = 2.08 X 10(3) l/mol. The number of binding sites was also the same in the two fluids. Although the concentration of piroxicam in synovial fluid was about half that in plasma, the binding of piroxicam to protein in synovial fluid was the same as in plasma.
Similar articles
-
Plasma protein binding and interaction studies with piroxicam.Naunyn Schmiedebergs Arch Pharmacol. 1984 Aug;327(1):81-5. doi: 10.1007/BF00504996. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6493354
-
Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.Eur J Clin Pharmacol. 1980 Nov;18(5):403-6. doi: 10.1007/BF00636793. Eur J Clin Pharmacol. 1980. PMID: 7439262
-
In vitro protein binding of diclofenac sodium in plasma and synovial fluid.J Pharm Sci. 1987 Feb;76(2):105-8. doi: 10.1002/jps.2600760204. J Pharm Sci. 1987. PMID: 3572745
-
Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.Clin Pharmacokinet. 1983 Nov-Dec;8(6):496-522. doi: 10.2165/00003088-198308060-00002. Clin Pharmacokinet. 1983. PMID: 6360465 Review.
-
Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.Clin Pharmacokinet. 1998 Jun;34(6):421-8. doi: 10.2165/00003088-199834060-00001. Clin Pharmacokinet. 1998. PMID: 9646006 Review.
Cited by
-
Effect of induced hypoalbuminemia on distribution, total clearance and unbound clearance of piroxicam in vivo in the rat.Eur J Drug Metab Pharmacokinet. 1993 Apr-Jun;18(2):165-71. doi: 10.1007/BF03188792. Eur J Drug Metab Pharmacokinet. 1993. PMID: 8243500
-
Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.Clin Pharmacokinet. 1989 Sep;17(3):145-62. doi: 10.2165/00003088-198917030-00002. Clin Pharmacokinet. 1989. PMID: 2680211 Review.
-
Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.Clin Pharmacokinet. 1987 Jun;12(6):402-32. doi: 10.2165/00003088-198712060-00002. Clin Pharmacokinet. 1987. PMID: 3301150 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical